Back to Search Start Over

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials.

Authors :
Klausen TW
Gregersen H
Abildgaard N
Andersen NF
Frølund UC
Gimsing P
Helleberg C
Vangsted AJ
Source :
Leukemia [Leukemia] 2019 Feb; Vol. 33 (2), pp. 546-549. Date of Electronic Publication: 2018 Sep 28.
Publication Year :
2019

Details

Language :
English
ISSN :
1476-5551
Volume :
33
Issue :
2
Database :
MEDLINE
Journal :
Leukemia
Publication Type :
Academic Journal
Accession number :
30267010
Full Text :
https://doi.org/10.1038/s41375-018-0272-0